Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

WILLOW SPRINGS, Ill. (WGN) — There has been an extraordinary step forward in the treatment of spinal cord injuries. For the patients who come through the door of the Next Steps clinic in southwest ...

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulation Devices Global Market Report by Product, Application, End User, Countries and Company Analysis, 2025-2033" has been added to ...

Spinal cord stimulators deliver mild electrical impulses to the spinal cord, which can disrupt pain signals before they reach the brain. As patients go about their daily lives, certain movements may ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to the Avantis spinal cord stimulation system (Reach Neuro, Inc), which has been shown in early testing to restore ...

People with chronic back pain may turn to spinal cord stimulation to ease their pain, but a Cochrane Review found no sustained benefits to the surgery that outweigh the costs and risks. Spinal cord ...

A device that stimulates the spinal cord is giving patients who suffer from chronic pain, a chance to live a normal life again. Shelby Eddy is a young mom who lives for her three boys. She says, ...

Melanie Reid was 52 years old when she hopped onto her horse, fell, and broke her neck. The resulting injury paralyzed her body below the chest area. Fourteen years later and after extensive physical ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Independent studies suggested that spinal cord stimulation ...

(MENAFN- GlobeNewsWire - Nasdaq) Regionally, North America leads, followed by Europe, with fast growth in Asia-Pacific. Challenges include high costs, surgery risks, and regulatory delays. Despite ...